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1. Introduction  
Urinary tract infection (UTI) is the most commonly diagnosed bacterial infection of 
childhood, and has a significant healthcare impact. Renal parenchymal infection and 
scarring are well-established complications of UTI in children and can lead to renal 
insufficiency, hypertension and renal failure. Although frequently encountered and well 
researched, diagnosis and management of UTI continue to be a controversial issue with 
many challenges for the clinician.  
The evolving state of knowledge about pediatric UTI leaves many questions and 
controversies. The goal of this chapter is to provide an up-to-date summary of the literature 
with particular attention to practical questions about diagnosis and management for the 
clinician. This chapter reviews also recent evidence regarding the epidemiology and 
evaluation of children with UTI. 
2. Definitions 
UTI is defined as the presence of bacteria in urine along with symptoms of infection. 
However, since asymptomatic colonization of the urinary tract can occur, other features such 
as the presence of inflammatory markers or follow-up cultures may be needed to definitively 
diagnose a UTI. 
UTIs have been classified in many ways: upper versus lower urinary tract, complicated 
versus uncomplicated, first episode versus recurrent, symptomatic versus asymptomatic, 
and according to severity simple versus severe infection.  
Pediatric UTIs are most simply categorized into two types: first infections and recurrent 
infections. Recurrent UTI is defined as two or more UTIs over a six-month period (Ditchfield 
et al., 1994). Recurrent UTI increases the risk of subsequent renal scarring. Recurrent UTI 
may be subclassified into three groups (Ma & Shortliffe, 2004): 
1. Unresolved infection: due to subtherapeutic level of antimicrobial (because of poor renal 
concentrating ability or gastrointestinal malabsorption), non-compliance with 
treatment, and resistant pathogens. Most unresolved infections are treated succesfully 
when proper culture and antimicrobial sensitivity patterns are available.  
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2. Bacterial persistence: may be due to a nidus in the urinary tract (Shortliffe, 1995). Surgical 
correction or medical treatment for urinary dysfunction may be needed. The surgically 
correctable sources of bacterial persistence are infection stones, infected nonfunctioning 
or poorly functioning kidneys or renal segments, infected ureteral stumps after 
nephrectomy, fistulas with bowels, infected necrotic papillae, and infected urachal cyst.    
3. Reinfection: each episode is a new infection acquired from periurethral, perineal or rectal 
flora. 
First childhood UTIs are considered complicated because of the evaluation and management 
implications. Lower UTI’s include bladder infections (cystitis), whereas upper UTI’s include 
pyelonephritis and perinephric and renal abscess. Ascending infection of the urinary tract is 
a complex process that has been associated with bacterial adhesion, virulence, and motility 
properties as well as host anatomic, humoral, and genetic factors (Svanborg & Godaly, 1997). 
The presence of fever, chills, and flank pain has usually been considered clinical evidence of 
upper tract infection. 
From the clinical point of view, UTI could also be classified as simple or severe UTI. Severe 
UTI is related to the presence of fever of > 390C, the feeling of being ill, persistent vomiting, 
and moderate or severe dehydration. A child with a simple UTI may have only mild 
pyrexia, but is able to take fluids and oral medication. The child is only slightly or not 
dehydrated and has a good expected level of compliance. When a low level of compliance is 
expected, such a child should be managed as one with a severe UTI. 
Breakthrough UTI may be caused by a change in the resistance pattern of organisms 
colonizing the urethra, noncompliance, vesicoureteral reflux (VUR) or dysfunctional 
voiding. Recognizing and addressing these associated factors are essential in treating 
breakthrough UTI.  
It is certainly possible to have bacteria within the urinary tract and be asymptomatic 
without having clinical infection or renal scarring. The prevalence of asymptomatic bacteriuria 
has been documented to be approximately 0.9% among young schoolgirls. Of these patients, 
10% were found to have VUR without any renal scarring. Controversy continues regarding 
the need for antibiotic treatment of asymptomatic bacteriuria (Schoen, 1990; Ahmed, 1996). 
If recurrent bacteriuria is truly asymptomatic, no antimicrobial treatment may be the best 
option, as some studies have shown that asymptomatic children are at very low risk of renal 
scarring, and prophylactic treatment did not decrease the risk of UTI recurrence (Shortliffe, 
1995). 
3. Epidemiology  
The epidemiology of UTI during childhood varies by age, gender, and other factors. The 
incidence of UTI in infants ranges from approximately 0.1 to 1.0 percent in all newborn 
infants to as high as 10 percent in low-birth-weight infants (Klein & Long, 1995). It 
represents the most common bacterial infection in children less than 2 years of age. It is the 
most common cause of fever of unknown origin in boys less than 3 years (Jodal, 1987). In the 
first year of life, mostly the first 3 months, UTI is more common in boys (3.7%) than in girls 
(2%), after which the incidence changes, being 3% in girls and 1.1% in boys (Foxman, 2002). 
Two studies of the prevalence of UTI among children presenting to an emergency 
department with fever found rates ranging from 3.5 to 5.5% (Hoberman et al., 1993; Shaw et 
al., 1998). Girls were more than twice as likely as boys to have UTI, and among boys, 
uncircumcised infants had an eightfold higher risk. This finding compares well with 
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population-based studies of UTI which document a 4- to 10-fold increase in risk of UTI 
among uncircumcised males during the first year of life, likely due to colonization of the 
mucosal surface of the foreskin with bacteria (To et al., 1998). White children were 
significantly more likely to have UTI than black children in both prevalence studies, with 
rates as high as 16 to 17% among white girls (Shaw et al., 1998). The reason for this increase 
associated with race is unclear, and referral bias may be a factor for these emergency 
department-based studies. However, some studies of white females suggest that there may 
be genetic tendencies for UTI, such as lack of secretion of carbohydrates that protect against 
bacterial adherence in the urinary tract (Jantausch et al., 1994; Sheinfeld et al., 1989).  
4. Importance of UTI 
The clinical significance of UTI has been controversial. In the preantibiotic era, UTI had a 
mortality rate as high as 20%, although acute complications in healthy children are now 
uncommon except in young infants, who may progress to systemic infection (Dayan et al., 
2004; Hansson et al., 1997). Long-term complications of UTI have been associated with renal 
scarring and include hypertension, chronic renal failure, and toxemia in pregnancy. Long-
term follow-up data are limited, although one Swedish study found that children diagnosed 
with renal scarring due to pyelonephritis during the 1950s and 1960s developed high rates of 
hypertension (23%) and end-stage renal disease (10%)(Jacobson et al., 1989). More recent 
studies question the association between pyelonephritis and end-stage renal disease 
(Esbjorner et al., 1997; Sreenarasimhaiah & Hellerstein, 1998). Although the individual risks 
associated with UTI remain unclear, the high prevalence of UTI and potential morbidity 
associated with complications require careful attention to diagnosis and management.  
5. Etiology 
Clinically important infections usually occur due to bacteria, although viruses, fungi, and 
parasites can also cause infection. Common bacterial pathogens include gram-negative 
species such as Escherichia coli, Klebsiella, Proteus, Enterobacter, Pseudomonas, and Serratia spp. 
and gram-positive organisms, including group B streptococci, Enterococcus sp., and 
Staphylococcus aureus. Escherichia coli is the most common infecting pathogen in children, 
accounting for up to 90 percent of UTIs (Shapiro, 1992). Gram-positive organisms represent 
5-7% of cases. Groups A and B streptococci are relatively common in the newborn (Richards 
et al., 1999). There is an increasing trend towards the isolation of Staphylococcus saprophyticus 
in UTIs in children, although the role of this organism is still debatable (Abrahamsson et al., 
1993). The virulence of the invading bacteria and the susceptibility of the host are of primary 
importance in the development of UTI (Feld, 1991).  
Fungi can cause cystitis in certain settings and with associated risk factors. Fungi are the 
second most common cause of nosocomial UTI in children, and can spread systemically and 
can be life-threatening. Risk factors for fungal UTI’s include the use of invasive devices 
(drains and catheters), previous broad-spectrum antibiotic exposure, and systemic 
immunosuppression. A true candidurial infection can be difficult to diagnose, since it can 
represent colonization, contamination, or infection, and may or may not have associated 
symptoms. The potential for candiduria to develop into invasive candidiasis in the neonatal 
intensive care unit is significant. Risk factors for this progression include prematurity, 
congenital urinary tract abnormalities, parenteral nutrition, respiratory intubation, and 
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umbilical artery or intravenous catheterization. Furthermore, the kidney is the most 
commonly affected organ in candidiasis, with “fungus balls” representing a life-threatening 
infection. As such, renal and bladder sonography is important in the evaluation of neonates 
with candiduria.  
Viral cystitis represents another form of non-bacterial UTI affecting children. Adenovirus 
types 11 and 21, Influenza A, polyomavirus BK, and Herpes simplex viruses can cause irritative 
voiding symptoms, hemorrhagic cystitis and even VUR or urinary retention. In non-
immunized or immunosuppressed children, Herpes zoster cystitis presents similarly. 
Fortunately, these forms of cystitis are self-limited. Immunosuppressed children undergoing 
kidney or bone marrow transplantation, or those receiving chemotherapy are especially 
susceptible to viral cystitis, including those caused by Cytomegalovirus and Adenoviruses 7, 21 
and 35. Antivirals such as ribavirin and vidarabine may be helpful when viral cystitis is 
diagnosed.  
6. Pathogenesis and risk factors 
In neonates, the usual route of infection is presumed to be hematogenous. Later in life, 
infection is usually caused by ascension of bacteria into the urinary tract. Retrograde ascent 
is the most common mechanism of infection. Any condition that leads to urinary stasis 
(renal calculi, obstructive uropathy, VUR and dysfunctional voiding) may predispose to the 
development of UTI in children (Batisky, 1996). Obstruction and dysfunctional voiding are 
among the most common causes of UTI (Ma & Shortliffe, 2004). A wide variety of congenital 
urinary tract abnormalities can cause UTIs through obstruction, e.g. urethral valves, 
ureteropelvic and ureterovesical junctions’ obstructions, ureteroceles, ectopic ureters, 
bladder extrophy, or non-obstructive urinary stasis (e.g. prune belly syndrome, VUR). More 
mundane but significant causes of UTIs include labial adhesion and chronic constipation 
(Abrahamsson et al., 1993).  
Phimosis is the inability to retract the foreskin, and is a anormal physiologic occurrence in 
newborn boys. Phimosis can predispose to UTI (Craig et al., 1996; To et al., 1998). The 
prepuce can serve as a reservoir for potentially uropathogenic bacteria. Enterobacteria 
derived from intestinal flora colonize the preputial sac, glandular surface and the distal 
urethra. Among these organisms are strains of E. coli expressing P fimbriae which adhere to 
the inner layer of the preputial skin and to uroepithelial cells (Fussel et al., 1988). 
Neuropathic bladder dysfunction (spina bifida, sphincter dyssynergia, etc) may also lead to 
postvoid residual urine and secondary VUR (Schulman, 2004). 
Dysfunctional voiding refers to dysfunction of the lower urinary tract in the absence of any 
apparent organic cause. The child with dysfunctional voiding habitually contracts the 
urethral sphincter during voiding. The term cannot be applied unless repeated urofow 
measurements have shown curves with a staccato pattern or if verified by invasive 
urodynamic investigation. Dysfunctional voiding may result in infrequent bladder 
emptying aided by delaying manoeuvres, e.g. crossing legs, sitting on heels (Wan et al., 
1995). It is often associated with daytime enuresis and constipation (Smith & Elder, 1994). 
Dysfunctional voiding can lead to secondary VUR, and may be exacerbated by chronic 
constipation because of alterations in pelvic floor activity caused by impacted stool. 
Normally, any bacteria that enter the bladder are flushed out of the bladder with complete 
and frequent voiding. Infrequent voiding and residual urine residual urine in the bladder 
allows bacteria that enter the bladder to grow and multiply enough to cause enfection. 
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Incomlete relaxation of the pelvic flor during voiding can couse poor compliance and/or 
incomplete emptying, both of which are thought to contribute to bacteriuria and UTI. Girls 
with recurrent UTIs have a particularly high incidence of voiding dysfunction (Chen et al., 
2004; Mingin et al., 2004) and should be screened with a thorough history, voiding diary, 
and appropriate clinical evaluation to rule out constipation. In children who demonstrate a 
high likelihood for this diagnosis, it may be appropriate to address these issues before 
proceeding to more invasive tests such as a VCUG. Treatment of voiding dysfunction 
includes timed voiding, treatment of constipation, prophylactic antibiotics and, in some 
cases, use of anticholinergic medication (e.g., oxybutynin) or biofeedback (Kibar et al., 2009, 
2007a, 2007b; Yagci et al., 2005). 
VUR is the abnormal retrograde flow of bladder urine into the upper urinary tract through 
an incompetent ureterovesical junction. Reflux in itself that is without bacterial 
contamination and low in pressure has not been documented to be deleterious. Reflux in the 
presence of bacteria as a risk factor for upper UTIs or pyelonephritis. In children without 
urologic symptoms or history of infection, the insidence of reflux is likely less than 1%. In 
children with a history of symptomatic UTI, the insidence of reflux has been estimated to 
range from 20% to 50%. Untreated upper UTIs have been shown to lead to acquired renal 
scarring or reflux nephropathy in children (Yeung et al., 1997). Controversy continues 
regarding the association of VUR with the pathogenesis of renal scarring, reflux 
nephropathy and pyelonephritis (Ditchfield et al., 1994; Eggli & Tulchinsky, 1993). Studies 
reporting on investigation during a febrile UTI document initial defect and subsequent 
scarring in 34 to 70% and 9.5 to 38%, respectively (Benador et al., 1997; Ditchfield & Nadel, 
1998; Hoberman et al., 2003; Majd & Rushton, 1992). Unfortunately, many studies do not 
have complete enough follow-up to determine the true incidence of scarring, as it has been 
shown that defects will change up to 6 months later (Ditchfield et al., 2002; Wallin et al., 
2001). There is also the potential for interobserver variability in renal scans, with differences 
ranging from small to notable (Gacinovic et al., 1996)). Children less than one year of age 
with a UTI are at much greater risk for renal scarring than older children; children over five 
years of age uncommonly have new renal scarring with UTI (Andrich & Majd, 1992). While 
some researchers emphasize the risk of renal scarring from recurrent UTI without reflux 
(Gordon, 1995), others are just as adamant regarding the risk of scarring from reflux in the 
absence of infection (Blumenthal, 1995). The fact that renal scarring develops in only a 
minority of patients with pyelonephritis and/or VUR suggests that the development of 
renal scarring likely involves the interplay of several factors and cannot simply be attributed 
to the presence of infection or reflux alone. 
7. Clinical presentation 
The presenting symptoms of UTI depend on the anatomic site of the infection and the age of 
the patient. Regardless of UTI location, infants and many young children cannot describe 
their symptoms; hence it is critical to understand the observable signs and symptoms of 
infection to make the diagnosis. In a child with so-called "asymptomatic" bacteriuria, only 
subtle clues, such as enuresis or squatting, may be present. Alternatively, a systemically ill 
neonate may be lethargic and hypotensive. 
Cystitis is second in frequency only to respiratory infection as a reason for pediatric medical 
visits. Classic symptoms of cystitis include urinary frequency, urgency, dysuria, hematuria, 
suprapubic pain, sensation of incomplete emptying, and even incontinence. Non-specific 
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symptoms can include poor feeding, irritability, lethargy, vomiting, diarrhea, ill appearance, 
and abdominal distension. Fever and flank pain are unusual symptoms for lower UTI.  
Pyelonephritis, and to a lesser degree renal abscesses, typically begin as a lower UTI that 
proceeds to an upper UTI as the infections ascends. However, pyelonephritis and renal 
abscesses can also result from hematogenous spread of infection (e.g., bacteremia). 
Symptoms that occur with upper UTI’s overlap those for cystitis, in part because cystitis is 
common in both. In upper UTI’s, flank pain and fevers (classically intermittent and >39°C) 
are more pronounced and important 
8. Diagnosis 
A thorough history from parents, and the child if possible, and a physical examination are 
essential in the evaluation of pediatric UTI.  There are no signs spesific for UTI in the infant. 
If there is a gross genitourinary anatomic abnormality, a renal mass may be palpable, as 
found in children with xanthogranulomatous pyelonephritis or infected severe 
hydronephrosis. Palpation in the suprapubic and flank areas may cause pain in the older 
child, but generelized abdominal or upper quadrant pain may also be present. Perineal 
examination rarely shows an ectopic ureteral opening, ureterocele, or ureteral discharge in 
girls. It is mandatory to look for phimosis and labial adhesion. Signs such as back scars, 
sacral fat pads, or sacral dimples or pits may suggest neurogenic bladder and may require 
further investigation. On boys, the testes are abnormal if affected by epididymitis or 
epididymo-orchitis. The absence of fever does not exclude the presence of an infective 
process. The presence of irritative urinary symptoms in the absence of bacteria suggests a 
non-UTI cause such as vaginitis, urethritis, pinworms, or the use of bubble baths (Zelikovic, 
1992). 
The question of when to screen for UTI has been evaluated in a number of studies. The 
presence of specific symptoms for UTI, including dysuria, frequency, urgency, suprapubic 
discomfort, and flank pain, should lead to screening. However, young children with UTI 
may present ith nonspecific symptoms, such as poor feeding, vomiting, irritability, jaundice 
(in newborns), or fever alone may be appropriate.  
Dipstick urinalysis is the most common initial laboratory testing, and may be the most cost-
effective screen for infant UTI. Urine cultures and blood cultures (if sepsis is suspected) are 
the mainstays of diagnosis. However, diagnosis is complicated by contamination from fecal 
bacteria that colonize the perineal area and distal urethra. The guideline issued by the 
American Academy of Pediatrics (AAP) for the evaluation of fever (39.0°C [102.2°F] or 
higher) of unknown origin suggests urinalysis in all cases and a urine culture in all boys 
younger than six months of age and all girls younger than two years of age (Baraff et al., 
1993). 
The definitive diagnosis of infection in children requires a positive urine culture (Ma & 
Shortliffe, 2004). Urine must be obtained under bacteriologically reliable conditions when 
undertaking a urine specimen culture (Zorc et al., 2005). A positive urine culture is defined 
as the presence of more than 100,000 cfu/mL of one pathogen. Most UTIs are caused by a 
single organism; the presence of two or more organisms usually suggests contamination. 
The urine specimen may be difficult to obtain in a child less than 4 years old and different 
methods are advised since there is a high risk of contamination (Watson, 2004). 
The final concentration of bacteria in urine is directly related to the method of collection, 
diuresis, and method of storage and transport of the specimen. In order to obtain a urine 
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sample in the best condition in children under 2 years of age (girls and uncircumcised boys 
without sphincteric control), it is better to use suprapubic bladder aspiration or bladder 
catheterization. In older children with sphincteric control, clean-voided midstream 
specimen is possible and reliable (Ma & Shortliffe, 2004). Voided specimen should be 
obtained after cleansing of the urethral meatus. Girls should be positioned backwards on the 
toilet seat to help spread the labia. Suprapubic bladder aspiration is the most sensitive 
method, but has a low rate of success unless aided by ultrasound visualization of urine in 
the bladder. Urine may be obtained in 23-99% of cases (Ma & Shortliffe, 2004). Bladder 
catheterization is also a sensitive method, even though there is the risk of introduction of 
nosocomial pathogens (Hellerstein, 2002). Urine from bagged and voided specimens are 
easier for the child, but have significant false positive rates, ranging from 85-99% (Ma & 
Shortliffe, 2004). It is helpful when the culture is negative and has a positive predictive value 
of 15% (Cavagnaro, 2005). Any number of colonies from a suprapubic bladder aspiration, 
more than 103 colonies from an intermittent catheterization, and more than 105 colonies from 
a midstream clean-catch urine collection indicate UTI (Batisky, 1996).  
Although urine culture is the gold standard for diagnosis of UTI, results are not available for 
24 to 48 h. Rapid techniques to predict UTI include urine dipstick tests for leukocyte esterase 
and nitrites and various forms of urinalysis, including standard microscopy on a centrifuged 
specimen, high-powered microscopy with a hemacytometer, and Gram stain of unspun 
urine for organisms.  
Nitrite is the degradation product of the nitrates of bacterial metabolism, particularly of 
Gram-negative bacteria. When an infection is caused by Gram-positive bacteria, the test may 
be negative (Ma & Shortliffe, 2004; Cavagnaro, 2005). Limitations of the nitrite test include: 
not all uropathogens reduce nitrate to nitrite (e.g. Pseudomonas aeruginosa, enterococci), even 
nitrite-producing pathogens may show a negative test result (due to the short transit time in 
the bladder in cases of high diuresis and urine dilution, e.g. neonates). The nitrite test has a 
sensitivity of only 45-60%, but a very good specificity of 85-98% (Ma & Shortliffe, 2004; 
Watson, 2004; Deville et al., 2004).   
Leucocyte esterase is produced by the activity of leucocytes. The test for leucocyte esterase 
has a sensitivity of 48-86% and a specificity of 17-93% (Ma and Shortliffe, 2004; Watson, 
2004; Hoberman & Wald, 1997; Deville et al., 2004). A combination of nitrite and leucocyte 
esterase testing improves sensitivity and specificity, but carries the risk of false-positive 
results (Deville et al., 2004). Back-up urine culture should be sent to detect the 
approximately 12% of UTIs that will be missed by the dipstick test (Huicho et al., 2002).The 
dipstick test has become useful to exclude rapidly and reliably the presence of a UTI, 
provided both nitrite and leucocyte esterase tests are negative. If the tests are positive, it is 
better to confirm the results in combination with the clinical symptoms and other tests 
(Watson, 2004; Deville et al., 2004).  
The presence or absence of pyuria on urinalysis, along with a urine culture, help make the 
diagnosis of pediatric UTI. Pyuria with a negative urine culture suggests viral infection, 
infection with fastidious organisms such as mycobacterium or haemophilus, or 
noninfectious cystitis. The lack of pyuria and a negative urine culture suggests a non-
infectious etiology for cystitis. A positive urine culture along with pyuria likely represents 
bacterial or fungal infection. A positive urine culture without pyuria may indicate 
contamination or an immunosuppressed host.  
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9. Evaluation after UTI 
After establishing the diagnosis of UTI, certain children require additional testing to 
determine possible causes for their infection. This is important as eradication of UTI with 
antibiotics may not be possible without correction of underlying structural abnormalities. In 
addition, the early diagnosis of anatomically based UTI’s can prevent or ameliorate long-
term sequelae of persistent or recurrent infections. The evaluation of children after a UTI 
was once thought to be quite straightforward and focused primarily on detecting and 
treating VUR in order to prevent end-stage renal disease from reflux nephropathy. Hutch 
and Hodson were among the first to describe a relationship between reflux and renal 
scarring. Subsequently, a relationship was established between reflux and chronic 
pyelonephritis (Smellie et al., 1964; Williams & Eckstein, 1965). Until recently, further 
evaluation of UTI has centered on the search for reflux with anatomic studies. AAP has 
suggested guidelines for radiologic imaging of children with UTIs. Urinary tract imaging is 
recommended in a febrile infant or young child between the ages of 2 months and 2 years 
with a first documented UTI. Typically this involves a renal and bladder ultrasound and a 
voiding cystourethrogram (VCUG) (AAP, 1999). 
10. Standard radiological studies 
There is more controversy than consensus regarding the appropriateness of different 
diagnostic imaging modalities in the evaluation of UTI in children (Slovis, 1995). A “Gold 
Standard” imaging technique has to be cost-effective, painless, safe, with minimal or no 
radiation, and an ability to detect any significant structural anomaly. Current techniques do 
not fulfil all such requirements. Imaging is indicated if patients have known anatomic 
structural abnormalities, unusual uropathogens such as Proteus or Mycobacterium 
tuberculosis, fail to improve with appropriate antimicrobial therapy, or have an unclear 
source of infection. VCUG should be performed as soon as a child is infection-free and 
bladder irritability has passed, since delaying the VCUG is associated with losing patients to 
follow-up. Other radiologic studies are computerized tomography (CT), magnetic resonance 
imaging (MRI), intravenous urography (IVU), and technetium-99m labeled dimercapto-
succinic acid (DMSA) and technetium-99m labeled mercaptoacetyl triglyceride (MAG-3) 
scans. The most commonly used imaging techniques are discussed in the following sections. 
IVU provides a precise anatomic image of the kidneys and can readily identify some urinary 
tract abnormalities (e.g., cysts, hydronephrosis) (Smellie, 1995a). The major disadvantages of 
IVU include decreased sensitivity compared with renal scintigraphy in the detection of both 
pyelonephritis and renal scarring (Smellie, 1995a). Higher dosage of radiation and risk of 
reaction to contrast medium are also reasons for concern. Given these disadvantages, IVU 
appears to have little role in the work-up of UTI in children, and the role of IVU is declining 
with the increasing technical superiority of CT (Huang et al., 1992) and MRI. However, the 
indication for their use is still limited in UTI.  
Although IVU has been a time-honored examination in the initial radiologic evaluation of 
UTI in children, ultrasonography (US) has largely replaced IVU as the initial screening 
examination (Rushton et al., 1992). US has become very useful in children because of its 
safety, speed and high accuracy in identifying the anatomy and size of the renal 
parenchyma and collecting system (Pickworth et al., 1995). Most physicians believe that it is 
an appropriate screening test to rule out major abnormalities. US alone is not generally 
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adequate for investigation of UTI in children, as it is unreliable in detecting VUR, renal 
scarring or inflammatory changes (Smellie, 1995a). It is subjective and therefore operator-
dependent, and gives no information on renal function. However, scars can be identified, 
although not as well as with DMSA scanning (Pickworth et al., 1995).   
VCUG is considered mandatory in the evaluation of UTIs in children less than 1 year of age. 
Typically, the contrast study is chosen for the first study due to its greater anatomic detail, 
although the radionuclide cystography has been shown in some studies to have a higher 
sensitivity (Polito et al., 2000). Radionuclide cystography is performed by prolonging the 
period of scanning after the injection of DTPA or MAG-3 as part of a dynamic renography. 
It represents an attractive alternative to conventional cystography, especially when 
following patients with reflux, because of its lower dose of radiation. Radiation dose used 
for this technique is only 1 percent of that used for standart VCUG (Batisky, 1996). Its 
continuous monitoring is also more sensitive for identifying reflux than the intermittent 
flouroscopic monitoring of VCUG. Disadvantages are a poor image resolution and difficulty 
in detecting lower urinary tract abnormalities (De Sadeleer et al., 1994; Piaggio et al., 2003). 
While debate exists regarding the timing of a VCUG study, it is generally accepted that it 
can be performed once the child is afebrile and has a negative urine culture, because VUR 
may be the transient effect of infection (Mahant et al., 2001). Compliance also appears to be 
better when the VCUG is performed early after a UTI (McDonald et al., 2000). However, 
because of low sensitivity and specificity, and because VCUG involves gonadal irradiation 
and catheterization, its use in diagnosing VUR has been questioned (Ditchfield et al., 1994; 
Haycock, 1991). In recent years, tailored low-dose fluoroscopic VCUG has been used for the 
evaluation of VUR in girls in order to minimize radiological exposure (Kleinman et al., 
1994). VCUG is mandatory in the assessment of febrile childhood UTI, even in the presence 
of normal ultrasonography. Up to 23% of these patients may reveal VUR (Kass et al., 2000). 
It can be performed as a standard contrast study or with a radionuclide.  
Renal cortical scintigraphy has replaced IVU as the standard technique for the detection of 
renal inflammation and scarring (Eggli & Tulchinsky, 1993). Technetium-99m labeled DMSA 
is a radiopharmaceutical that is bound to the basement membrane of proximal renal tubular 
cells. This technique is highly sensitive and specific. This technique ensures an accurate 
diagnosis of cortical scarring by showing areas of hypoactivity indicating lack of function. 
DMSA scanning offers the advantages of earlier detection of acute inflammatory changes 
and permanent scars compared with US or IVU (Bircan et al., 1995; MacKenzie et al., 1994). 
It is also useful in neonates and patients with poor renal function. UTI interferes with the 
uptake of this radiotracer by the proximal renal tubular cells, and may show areas of focal 
defect in the renal parenchyma. A star-shaped defect in the renal parenchyma may indicate 
an acute episode of pyelonephritis. A focal defect in the renal cortex usually indicates a 
chronic lesion or a renal scar (Kass, 1994; Britton, 1998). A focal scarring or a smooth 
uniform loss of renal substance has generally been regarded as being associated with VUR 
(reflux nephropathy) (Rosenberg et al., 1992). The use of Tc-99m DMSA scans can be helpful 
in the early diagnosis of acute pyelonephritis. About 50-85% of children will show positive 
findings in the first week. Minimal parenchymal defects, when characterized by a slight area 
of hypoactivity, can resolve with antimicrobial therapy (Risdon et al., 1994). However, 
defects lasting longer than 5 months are considered to be renal scarring (Jakobsson & 
Svensson, 1997). CT is sensitive and specific for the detection of acute pyelonephritis, but CT 
is more expensive than scintigraphy and exposes the patient to higher levels of radiation, 
and its use is not supported by evidence. 
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Contrast material-enhanced voiding ultrasonography has been introduced for the diagnoses 
of VUR without irradiation (Westwood et al., 2005; Piaggio et al., 2003). Further studies are 
necessary to determine the role of this new imaging modality in UTI. 
When voiding dysfunction is suspected, e.g. incontinence, increased residual urine, 
increased bladder wall thickness, urodynamic evaluation with uroflowmetry and 
electromyography should be considered. 
11. Schedule of investigation  
Screening of infants for asymptomatic bacteriuria is unlikely to prevent pyelonephritic scar 
formation, as these usually develop very early in infancy. Only a minority of children with a 
UTI have an underlying urological disorder, but when present such a disorder can cause 
considerable morbidity. Thus, after a maximum of two UTI episodes in a girl and one 
episode in a boy, investigations should be, but not in the case of asymptomatic bacteriuria 
(Piaggio et al., 2003; Melis et al., 1992; Smellie 1995b). The need for DTPA/MAG-3 scanning 
is determined by the ultrasound findings, particularly if there is suspicion of an obstructive 
lesion. 
12. Treatment 
Therapeutic trials in children with UTI are rare and poorly controlled (Helwig, 1994). Thus, 
controversy regarding dosage or length of therapy with antimicrobials continues. 
Treatment’s goals are elimination of symptoms and eradication of bacteriuria in the acute 
episode, prevention of a recurrent UTI, prevention of renal scarring, and correction of 
associated urological lesions. Initial antibiotic therapy should be based on age, clinical 
severity, location of infection, presence of structural abnormalities, and allergy to certain 
antibiotics.  
Hospitalization is suggested for symptomatic young infants (less than three months of age) 
and all children with clinical evidence of acute severe pyelonephritis (high fever, toxic 
appearance, severe flank pain) (Berman, 1991). Parenteral fluid replacement and appropriate 
antimicrobial treatment, preferably with cephalosporins (third generation) should be given. 
In patients with an allergy to cephalosporins, aztreonam or gentamicin may be used. If a 
Gram-positive UTI is suspected by Gram stain, it is useful to administer aminoglycosides in 
combination with ampicillin or amoxycillin/clavulanate (Smellie, 1995b). Treatment 
generally begins with a broad-spectrum antibiotic, but it may need to be changed based on 
the results of urine culture and sensitivity testing.  
When the child becomes afebrile and is able to take fluids, he/she may be given an oral 
agent to complete the 10-14 days of treatment, which may be continued on an outpatient 
basis (Hoberman & Wald, 1997). The preferred oral antimicrobials are: trimethoprim (TMP), 
TMP plus sulphamethoxazole (co-trimoxazole), an oral cephalosporin, or 
amoxicillin/clavulanate. In children less than 3 years of age, who have difficulty taking oral 
medications, parenteral treatment for 7-10 days seems advisable, with similar results to 
those with oral treatment (Bloomfield et al., 2005). 
The choice of antibiotic may be affected by local resistance patterns and other 
considerations. Amoxicillin was traditionally the first-line therapy for outpatient treatment 
of UTI in children. However, increased rates of Escherichia coli resistance have made 
amoxicillin a less acceptable choice, and studies have found higher cure rates for co-
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trimoxazole (AAP, 1999). Fluoroquinolones are widely used in adult patients, although 
concerns about potential effects on musculoskeletal joint development based on animal data 
have restricted their use in young children. A recent review of the use of for pediatric UTI 
noted a high rate of efficacy among patients with complex medical conditions or multidrug 
resistance, although data on the safety of these agents are limited (Koyle et al., 2003). 
Fluoroquinolones may be used as second-line therapy in the treatment of serious infections 
(Grady, 2003). Chloramphenicol, sulphonamides, tetracyclines, rifampicin and amphotericin 
B should be avoided. The use of ceftriaxone must also be avoided due to its undesired side 
effect of jaundice.   
The duration of outpatient treatment for patients with a less toxic appearance and 
uncomplicated UTI (no systemic signs of infection) is also controversial (Zelikovic et al., 
1992) Evidence is lacking for the use of short-course therapy in children with UTI 
(Hellerstein, 1994). Oral empirical treatment with TMP, an oral cephalosporin or 
amoxycillin/clavulanate is recommended, according to the local resistance pattern. The 
duration of treatment in uncomplicated UTIs treated orally should be 5-7 days (Michael et 
al., 2003; Tran et al., 2001). A single parenteral dose may be used in cases of doubtful 
compliance and with a normal urinary tract (Khan, 1994). If the response is poor or 
complications develop, the child must be admitted to hospital for parenteral treatment 
(Hellerstein, 1995). 
There is no consensus regarding the treatment of pediatric candiduria. Measures include 
stopping antibiotics, removing or changing indwelling catheters, and antifungal therapy. 
Commonly used antifungal agents include oral fluconazole and parenteral or intravesical 
amphotericin B. In patients with obstruction or failure to improve with medical 
management, urgent percutaneous nephrostomy tube placement to drain the kidney may be 
needed. Additional measures include amphotericin B irrigation of the nephrostomy tube, or 
even nephrectomy in severe cases.  
13. Prophylaxis 
If there is an increased risk of pyelonephritis, e.g. VUR, and recurrent UTI, low-dose 
antibiotic prophylaxis is recommended (Smellie et al., 1988; Arant, 2001). It may also be used 
after an acute episode of UTI until the diagnostic work-up is completed. The most effective 
antimicrobial agents are: nitrofurantoin, TMP, cephalexin and cefaclor (Smellie et al., 1988). 
14. Conclusions 
UTI is a common pediatric problem with the potential to produce long-term morbidity. 
Renal parenchymal infection and scarring are well-established complications of UTI in 
children and can lead to renal insufficiency, hypertension and renal failure. The clinical 
presentation of UTI is variable. Young children presenting with fever may have nonspecific 
symptoms of UTI, and a high index of suspicion is appropriate in this setting. Although 
culture of the urine remains the gold standard for diagnosing and treating UTIs, technical 
considerations including method of collection of the urine as well as the time necessary for 
culture results remain problematic. The appropriate treatment of UTI is controversial and 
becomes more complex with the emergence of resistance to commonly used antibiotics. The 
length of antibiotic therapy for UTI in children is also an area of controversy. Therapeutic 
trials in children with UTI are rare and poorly controlled. Thus, controversy regarding 
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dosage or length of therapy with antimicrobials continues. The diagnostic work-up should 
be tailored to uncover functional and structural abnormalities such as dysfunctional 
voiding, VUR and obstructive uropathy. A more aggressive work-up, including renal 
cortical scintigraphy, ultrasound and voiding cystourethrography, is recommended for 
patients at greater risk for pyelonephritis and renal scarring, including infants less than one 
year of age and all children who have systemic signs of infection concomitant with a UTI. 
Antibiotic prophylaxis is used in patients with reflux or recurrent UTI who are at greater 
risk for subsequent infections and complications.  
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